Brisa Burgos Dias Macedo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brisa Burgos Dias Macedo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Cristiane Von Werne Baes
Department of Neuroscience and Behavior, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo 14049-900, Brazil
2 shared publications - Ana Carolina Bueno
Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14015-130, Brazil
1 shared publication - Catarina Nívea Bezerra B. Menezes
Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto
1 shared publication - Fernanda Viana Fígaro-Drumond
Department of Psychiatric Nursing and Human Sciences, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto 14040-902, Brazil
1 shared publication - Itiana Castro Menezes
Department of Neuroscience and Behavior, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo 14049-900, Brazil
1 shared publication Josenília Maria Alves Gomes
1 shared publication
Latest Publications
- Open Access
- 31 October 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1476
Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress
Few studies have assessed biomarkers for the differentiation of major depressive disorder (MDD) and bipolar disorder (BD). However, some elements of depression such as hormones and receptors of the renin–angiotensin–adrenal system (RAAS), the hypothalamus–pituitary–adrenal (HPA) axis, and history of early-life stress (ELS) could be considered for differential diagnosis. Therefore, this study aimed to assess aldosterone and cortisol levels, MR and GR gene polymorphisms, and ELS as potential biomarkers for differentiating MDD and BD. This study presents a case–control design. Groups comprised samples for genetic, cortisol, and aldosterone analysis: healthy control (HC; n = 113/97/103), MDD (n = 78/69/67) and BD (n = 82/68/65) subjects. Furthermore, all subjects were assessed for diagnostic screening, the severity of depression, and history of ELS by applying MINI-PLUS, GRID-HDRS, and CTQ, respectively. In addition, genotype and allelic frequencies of GR (N363S, R22/23K and BclI) and MR (MI180V and -2G/C) polymorphisms were evaluated via PCR. Our findings demonstrate that basal aldosterone levels may be a biomarker for differentiating BD and MDD. Furthermore, ELS affects the HPA axis in BD, cortisol may be considered a biomarker for distinguishing BD and MDD, but only in the absence of ELS, and, finally, history of ELS and MR-2G/C variant alleles are factors that contribute to the severity of depressive symptoms in MDD and BD.
- 31 October 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1476
Open AccessDifferential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress
Few studies have assessed biomarkers for the differentiation of major depressive disorder (MDD) and bipolar disorder (BD). However, some elements of depression such as hormones and receptors of the renin–angiotensin–adrenal system (RAAS), the hypothalamus–pituitary–adrenal (HPA) axis, and history of early-life stress (ELS) could be considered for differential diagnosis. Therefore, this study aimed to assess aldosterone and cortisol levels, MR and GR gene polymorphisms, and ELS as potential biomarkers for differentiating MDD and BD. This study presents a case–control design. Groups comprised samples for genetic, cortisol, and aldosterone analysis: healthy control (HC; n = 113/97/103), MDD (n = 78/69/67) and BD (n = 82/68/65) subjects. Furthermore, all subjects were assessed for diagnostic screening, the severity of depression, and history of ELS by applying MINI-PLUS, GRID-HDRS, and CTQ, respectively. In addition, genotype and allelic frequencies of GR (N363S, R22/23K and BclI) and MR (MI180V and -2G/C) polymorphisms were evaluated via PCR. Our findings demonstrate that basal aldosterone levels may be a biomarker for differentiating BD and MDD. Furthermore, ELS affects the HPA axis in BD, cortisol may be considered a biomarker for distinguishing BD and MDD, but only in the absence of ELS, and, finally, history of ELS and MR-2G/C variant alleles are factors that contribute to the severity of depressive symptoms in MDD and BD.
- Open Access
- 2 February 2018
- Published by Fundacao Edson Queiroz in Revista Humanidades
- Vol. 32 (2) , 193-203
Consequências da personalidade borderline na adesão ao tratamento de dores crônicas
O Transtorno da Personalidade Borderline (TPB) é tema recorrente em saúde mental devido aos prejuízos acarretados aos aspectos emocionais, interpessoais, cognitivos, comportamentais e de identidade do paciente. O objetivo deste artigo radica em debater sobre a interferência do TPB na adesão ao tratamento das dores crônicas e em como a Terapia Comportamental Dialética pôde ser aplicada neste caso. Para tanto, foi realizado um estudo de caso, decorrentes dos atendimentos de Karla, paciente com TPB e diagnóstico de fibromialgia. Notou-se que a situação de desregulação, bem como a baixa adesão ao tratamento, foi elemento importante para o baixo rendimento do tratamento.
- 2 February 2018
- Published by Fundacao Edson Queiroz in Revista Humanidades
- Vol. 32 (2) , 193-203
Open AccessConsequências da personalidade borderline na adesão ao tratamento de dores crônicas
O Transtorno da Personalidade Borderline (TPB) é tema recorrente em saúde mental devido aos prejuízos acarretados aos aspectos emocionais, interpessoais, cognitivos, comportamentais e de identidade do paciente. O objetivo deste artigo radica em debater sobre a interferência do TPB na adesão ao tratamento das dores crônicas e em como a Terapia Comportamental Dialética pôde ser aplicada neste caso. Para tanto, foi realizado um estudo de caso, decorrentes dos atendimentos de Karla, paciente com TPB e diagnóstico de fibromialgia. Notou-se que a situação de desregulação, bem como a baixa adesão ao tratamento, foi elemento importante para o baixo rendimento do tratamento.